YUNMAI
21.7.2022 11:53:08 CEST | Business Wire | Press release
The leading wellness equipment brand Yunmai is announcing the #YunmaiAthletes community campaign. Yunmai serves professional players across different sports by supporting them with professional, effective, and portable muscle recovery solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220718005331/en/
In April 2021, Yunmai announced its first Global Brand Ambassador, Ansu Fati, the "New No. 10" from FC Barcelona, who inherited the number from Lionel Messi, for its line of massage guns. “Join Yunmai Athletes, enter a new dimension, and achieve your peak athletic performance,” said Ansu Fati. At the young age of 17 years, Fati had already set athletic world records that made him the obvious choice to represent Yunmai on a global stage.
Yunmai‘s products are designed to empower sports enthusiasts and especially professional athletes to fully control their fitness and wellness. For many athletes, Yunmai massage guns have been part of their daily training routine to enhance their performance during competitions. In addition to Ansu Fati, the world’s No. 1 Badminton player Viktor Axelsen, who has won two Olympic medals, favors his Yunmai Massage Gun Pro Basic: “To keep my training session challenging, it's essential to have Yunmai relaxation gadgets at my disposal.”
Three-time Olympic gold medalist Kaillie Humphries also approves of the powerful Yunmai Massage Gun Slim Chic: “Whether I'm warming up before lifting or cooling down after a competition, the Yunmai massage gun helps me recover faster.” Humphries’ hard training and winning moments on the field are enabled by Yunmai’s high-quality percussive therapy devices to improve her pre-workout activation and post-workout muscle recovery.
Yunmai is dedicated to help users “Simplify Your Workout” and unlock the best version of themselves with quick warm-ups, instant recovery, and precise data tracking. “I love how Yunmai lets me take control of recovery in a simple and efficient way,” explained Joey Haywood, the streetball legend from Canada.
Yunmai specializes in technology-driven massage guns, smart scales, and smart jump ropes, which are sold in over 115 countries today. Yunmai’s award-winning products have been featured in a wide range of well-known global media outlets, including CNN, Forbes, Rolling Stone, and the Wall Street Journal.
About Yunmai
The sports and fitness brand Yunmai has been using technology and innovation to enhance workouts since 2014. Yunmai pioneered the manufacturing of smart scales and continues to innovate in the smart health market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220718005331/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software26.6.2026 23:28:00 CEST | Press release
Powered by the risk-centric PASTA methodology and two decades of accredited offensive security, the integrated platform lets enterprises threat model in a security sprint—then prove the risk through AI-led, human-on-the-loop testing. VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained s
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 22:30:00 CEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse
Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release
Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom